Effects of Tamoxifen in skeletal muscle recovery after spinal cord injury and mechanisms activated by the drug
他莫昔芬对脊髓损伤后骨骼肌恢复的影响及其激活机制
基本信息
- 批准号:10331118
- 负责人:
- 金额:$ 36.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAftercareAnimal ModelAnimalsAntineoplastic AgentsApoptosisAreaAtrophicAxonCell ProliferationDataDesminDevelopmentEmbryoEnvironmentEstradiolEstrogen ReceptorsEventExerciseFDA approvedFemaleFiberHumanImplantInflammationInjuryLaboratoriesLeadLocomotor RecoveryMetabolicMolecularMotor ActivityMovementMuscleMuscle CellsMuscle FibersMuscular AtrophyMyogeninMyosin ATPaseMyosin Heavy ChainsNatural regenerationNerveNerve RegenerationNerve TissuePainParalysedPathway interactionsPatientsPerceptionPharmaceutical PreparationsPharmacological TreatmentPhaseProcessPropertyProtein IsoformsProteinsRattusRecoveryRecovery of FunctionReportingResearchResearch PersonnelSelective Estrogen Receptor ModulatorsSex DifferencesSkeletal MuscleSoleus MuscleSpinal CordSpinal Cord ContusionsSpinal cord injuryTamoxifenTestingTherapeuticTissuesTraumaeffective therapyexercise programexercise rehabilitationexperimental studyimprovedinjuredinnovationmalemetabolic profilemetabolomicsmotor recoverymuscle degenerationmuscle physiologymuscle regenerationneuron lossneuronal circuitrynovel therapeutic interventionpreservationpreventprotein degradationregenerativerelating to nervous systemrepairedresponsesatellite cellsexsexual dimorphismsomatosensorytibialis anterior muscletreatment effect
项目摘要
Spinal cord injury (SCI) is a condition without a cure, characterized by the loss of somatosensory perception
and voluntary movement eventually resulting in muscle atrophy. Most research has focused on nerve
regeneration not muscle recovery, although nerve regeneration is useless if muscle deterioration is beyond
repair. Exercise soon after the injury is a common therapy to reduce muscle atrophy in animal models, but in
humans it is not possible in the acute phase after trauma. An effective therapy must reduce muscle
degeneration and improve muscle contractile properties in the acute phase after SCI until exercise is possible.
Our laboratory is pioneering the use of tamoxifen (TAM), an FDA-approved cancer drug, to reduce muscle
degeneration after trauma. TAM, a selective estrogen receptor modulator, could reverse the changes in muscle
type composition and reduce the SCI-induced effect on muscle fiber contractile properties because estradiol,
working through estrogen receptors (ER), has these effects. In addition, TAM has the potential benefit that it
could stimulate Satellite cell activation/proliferation. The interaction of TAM with different ERs suggests that
there is a possible sex difference in the response to this drug. Since sexual differences have been observed in
muscle fibers and contractile properties, new studies are necessary to define the effect of TAM in female and
male muscle tissue after SCI. Our preliminary data demonstrate that TAM improves locomotor recovery and
prevents myosin loss in muscle tissue. Therefore, our central hypothesis is that TAM, administered early
after SCI, will partially preserve the contractile properties of muscle fibers, reducing degeneration, and
ultimately increase myofiber proliferation/regeneration. In addition, we want to explore a possible sex
difference in the response to this drug and the metabolic profile activated or de-activated in muscle cells after
SCI. The present project has the following aims: AIM 1. To determine the effect of TAM to prevent a reduction
in the contractile properties of skeletal muscle fibers after SCI in male and female rats, and establish the
mechanisms by which this drug prevents muscle degeneration. We will implant TAM pellets in male and
female rats after a moderate contusion SCI. Contractile properties of Soleus and Tibialis anterior muscle fibers
will be evaluated and the expression profile of myosin heavy chain (MHC) isoforms will be studied at 7, 14, and
28 days post-injury (DPI). AIM 2. To evaluate the effect of TAM on myogenic factors and
proliferative/regenerative proteins from skeletal muscle after SCI and establish if the effects in these cellular
events are sex-specific. Male and female rats will be treated with TAM after SCI. The effect of this drug on
Soleus and Tibialis expression of myogenic factors (Pax7, MyoD and myogenin), used as markers of Satellite
cell activation or proliferation and proteins associated to new muscle fiber formation (desmin and embryonic
MHC) will be tested at 7, 14, and 28 DPI. These experiments and their results may lead to novel therapeutic
strategies that enhance muscle and locomotor recovery after SCI.
脊髓损伤(SCI)是一种无法治愈的疾病,以躯体感觉知觉丧失为特征
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JORGE David MIRANDA其他文献
JORGE David MIRANDA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JORGE David MIRANDA', 18)}}的其他基金
Neuroimaging and Electrophysiology Facility (NIEF)
神经影像和电生理学设施 (NIEF)
- 批准号:
10628976 - 财政年份:2023
- 资助金额:
$ 36.95万 - 项目类别:
Effects of Tamoxifen in skeletal muscle recovery after spinal cord injury and mechanisms activated by the drug
他莫昔芬对脊髓损伤后骨骼肌恢复的影响及其激活机制
- 批准号:
10599843 - 财政年份:2022
- 资助金额:
$ 36.95万 - 项目类别:
Role of Eph Receptors after Spinal Cord Injury
Eph 受体在脊髓损伤后的作用
- 批准号:
6766633 - 财政年份:2004
- 资助金额:
$ 36.95万 - 项目类别:
EXPRESSION OF EPHRINS B PROTEIN AFTER SPINAL CORD INJURY
脊髓损伤后 Ephrins B 蛋白的表达
- 批准号:
6644310 - 财政年份:2002
- 资助金额:
$ 36.95万 - 项目类别:
Ephrin A receptor tyrosine kinases in preventing axonal regeneration
Ephrin A 受体酪氨酸激酶预防轴突再生
- 批准号:
6667572 - 财政年份:2002
- 资助金额:
$ 36.95万 - 项目类别:
EXPRESSION OF EPHRINS B PROTEIN AFTER SPINAL CORD INJURY
脊髓损伤后 Ephrins B 蛋白的表达
- 批准号:
6660088 - 财政年份:2002
- 资助金额:
$ 36.95万 - 项目类别:
Ephrin A receptor tyrosine kinases in preventing axonal regeneration
Ephrin A 受体酪氨酸激酶预防轴突再生
- 批准号:
6504181 - 财政年份:2001
- 资助金额:
$ 36.95万 - 项目类别:
EXPRESSION OF EPHRINS B PROTEIN AFTER SPINAL CORD INJURY
脊髓损伤后 Ephrins B 蛋白的表达
- 批准号:
6504120 - 财政年份:2001
- 资助金额:
$ 36.95万 - 项目类别:
Ephrin A receptor tyrosine kinases in preventing axonal regeneration
Ephrin A 受体酪氨酸激酶预防轴突再生
- 批准号:
6358524 - 财政年份:2000
- 资助金额:
$ 36.95万 - 项目类别:
Ephrin A receptor tyrosine kinases in preventing axonal regeneration
Ephrin A 受体酪氨酸激酶预防轴突再生
- 批准号:
6357116 - 财政年份:2000
- 资助金额:
$ 36.95万 - 项目类别:
相似海外基金
Life outside institutions: histories of mental health aftercare 1900 - 1960
机构外的生活:1900 - 1960 年心理健康善后护理的历史
- 批准号:
DP240100640 - 财政年份:2024
- 资助金额:
$ 36.95万 - 项目类别:
Discovery Projects
Development of a program to promote psychological independence support in the aftercare of children's homes
制定一项计划,促进儿童之家善后护理中的心理独立支持
- 批准号:
23K01889 - 财政年份:2023
- 资助金额:
$ 36.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:
10452217 - 财政年份:2022
- 资助金额:
$ 36.95万 - 项目类别:
Integrating Smoking Cessation in Tattoo Aftercare
将戒烟融入纹身后护理中
- 批准号:
10670838 - 财政年份:2022
- 资助金额:
$ 36.95万 - 项目类别:
Aftercare for young people: A sociological study of resource opportunities
年轻人的善后护理:资源机会的社会学研究
- 批准号:
DP200100492 - 财政年份:2020
- 资助金额:
$ 36.95万 - 项目类别:
Discovery Projects
Creating a National Aftercare Strategy for Survivors of Pediatric Cancer
为小儿癌症幸存者制定国家善后护理策略
- 批准号:
407264 - 财政年份:2019
- 资助金额:
$ 36.95万 - 项目类别:
Operating Grants
Aftercare of green infrastructure: creating algorithm for resolving human-bird conflicts
绿色基础设施的善后工作:创建解决人鸟冲突的算法
- 批准号:
18K18240 - 财政年份:2018
- 资助金额:
$ 36.95万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an aftercare model for children who have experienced invasive procedures
为经历过侵入性手术的儿童开发善后护理模型
- 批准号:
17K12379 - 财政年份:2017
- 资助金额:
$ 36.95万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of a Comprehensive Aftercare Program for children's self-reliance support facility
为儿童自力更生支持设施制定综合善后护理计划
- 批准号:
17K13937 - 财政年份:2017
- 资助金额:
$ 36.95万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Project#2 Extending Treatment Effects Through an Adaptive Aftercare Intervention
项目
- 批准号:
8742767 - 财政年份:2014
- 资助金额:
$ 36.95万 - 项目类别: